You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Phase 1 Clinical Trial

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Atopic Dermatitis Trial in Shanghai (0.1% QY211 Gel or , 0.3% QY211 Gel or , 0.8% QY211 Gel or )

Recruiting
  • Atopic Dermatitis
  • 0.1% QY211 Gel or placebo
  • +3 more
  • Shanghai, Shanghai, China
    Huashan Hospital Affiliated to Fudan University
Apr 24, 2023

Mature B-cell Tumors Trial (Nemtabrutinib)

Not yet recruiting
  • Mature B-cell Neoplasms
  • (no location specified)
Jan 13, 2023

Healthy Adult Volunteers Trial in Beijing (VSA001 injection, Placebo)

Not yet recruiting
  • Healthy Adult Volunteers
  • VSA001 injection
  • Placebo
  • Beijing, Beijing, China
    Peking University Third Hospital
Feb 23, 2023

Hematologic Malignancy Trial in Tianjin (IMM01)

Terminated
  • Hematologic Malignancy
  • Tianjin, Tianjin, China
    Chinese Academy of Medical Sciences and Peking Union Medical Col
May 5, 2023

Solid Tumor, Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial (ES014)

Not yet recruiting
  • Solid Tumor
  • +2 more
  • (no location specified)
Jan 28, 2023

SARS-CoV-2 Trial (SARS-CoV-2 variant mRNA vaccine low dose, SARS-CoV-2 variant mRNA vaccine high dose)

Not yet recruiting
  • SARS-CoV-2
  • SARS-CoV-2 variant mRNA vaccine low dose
  • SARS-CoV-2 variant mRNA vaccine high dose
  • (no location specified)
Oct 30, 2022

Healthy Subjects Trial in Shanghai (injection ,CU-20401, injection ,)

Recruiting
  • Healthy Subjects
  • injection ，CU-20401
  • injection ，placebo
  • Shanghai, Shanghai, China
    Shanghai Xuhui Hospital
Jul 22, 2022

Essential Hypertension Trial (NW Roselle, Captopril 25Mg Tab)

Not yet recruiting
  • Essential Hypertension
  • NW Roselle
  • Captopril 25Mg Tab
  • (no location specified)
Nov 15, 2023

Hiv Trial in United States (V3G CH848 Pr-NP1 60mcg, 3M-052-AF 5mcg, Alum 500 mcg)

Not yet recruiting
  • Hiv
  • V3G CH848 Pr-NP1 60mcg
  • +5 more
  • Birmingham, Alabama
  • +5 more
Jun 5, 2023

Healthy Trial in Beijing (MT200605 for Injection, MT200605 Placebo)

Enrolling by invitation
  • Healthy
  • MT200605 for Injection
  • MT200605 Placebo
  • Beijing, Beijing, China
    Beijing Friendship Hospital, Capital Medical University
Jul 13, 2023

Prostate Cancer Trial in Seoul (SOL-804-F, Zytiga)

Recruiting
  • Prostate Cancer
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Aug 25, 2023

Healthy Volunteers Trial in Groningen (5 Methoxy N,N Dimethyltryptamine, Placebo)

Recruiting
  • Healthy Volunteers
  • 5 Methoxy N,N Dimethyltryptamine
  • Placebo
  • Groningen, Netherlands
    GH Research Clinical Trial Site
Feb 23, 2023

Malignant Melanoma, Angiosarcoma Trial in Chuo Ku (CICS-1 (investigational device),SPM-011(investigational drug))

Active, not recruiting
  • Malignant Melanoma
  • Angiosarcoma
  • CICS-1 (investigational device),SPM-011(investigational drug)
  • Chuo Ku, Tokyo, Japan
    National Cancer Center Hospital
Nov 6, 2022

Mild Cognitive Impairment, Alzheimer Dementia Trial (CpG1018, Placebo)

Not yet recruiting
  • Mild Cognitive Impairment
  • Alzheimer Dementia
  • (no location specified)
Jan 3, 2023

Glioblastoma Trial in Milwaukee (Gallium maltolate (500 mg), Gallium maltolate (1,000 mg), Gallium maltolate (1,500 mg))

Recruiting
  • Glioblastoma
  • Gallium maltolate (500 mg)
  • +3 more
  • Milwaukee, Wisconsin
    Froedtert Hospital & the Medical College of Wisconsin
Sep 20, 2022

Prostatic Tumors, Metastatic Castration-Resistant Prostate Cancer Trial (MK-5684, Dexamethasone, Fludrocortisone acetate)

Not yet recruiting
  • Prostatic Neoplasms
  • Metastatic Castration-Resistant Prostate Cancer
  • (no location specified)
Oct 23, 2023

Healthy Trial in Seoul (CTO0101, Placebo (vehicle))

Recruiting
  • Healthy
  • Seoul, Korea, Republic of
    Taejoon Pharmaceutical Co., Ltd.
Feb 21, 2022

Prostatic Tumors, Metastatic Castration-Resistant Prostate Cancer Trial (MK-5684, Dexamethasone, Fludrocortisone)

Not yet recruiting
  • Prostatic Neoplasms
  • Metastatic Castration-Resistant Prostate Cancer
  • (no location specified)
Nov 13, 2023

Advanced Solid Tumors Trial in Guangdong (JS019)

Recruiting
  • Advanced Solid Tumors
  • JS019
  • Guangdong, Guangzhou, China
    Guangdong General Hospital
Aug 17, 2022

Healthy Trial in Seoul (CKR-051 Dose 1, CKR-051 Dose 2, CKR-051 Dose 3)

Not yet recruiting
  • Healthy
  • CKR-051 Dose 1
  • +4 more
  • (no location specified)
Apr 18, 2023

Healthy Trial in Seoul (C1K 150mg, C1K 300mg, Placebo with the same volume of C1K 300mg)

Recruiting
  • Healthy
  • C1K 150mg
  • +8 more
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Jan 25, 2023

Solid Tumor, Advanced Solid Tumor Trial (PYX-201)

Not yet recruiting
  • Solid Tumor
  • Advanced Solid Tumor
  • (no location specified)
Feb 9, 2023

Osteoarthritis, Rheumatoid Arthritis, Back Pain Trial in Cheongju-si (DW1809, DW1809-1)

Completed
  • Osteoarthritis
  • +3 more
  • Cheongju-si, Korea, Republic of
    Chungbuk National University Hospital
Jan 28, 2022

NSCLC Trial (QLH11811)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • (no location specified)
Sep 22, 2022

NSCLC Trial (Phase I - Mirdametinib - Level 1, Phase II - Mirdametinib, Phase I - Mirdametinib - Level 2)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Phase I - Mirdametinib - Level 1
  • +4 more
  • (no location specified)
Jul 7, 2023